OrganiGram Holdings Inc.
TSX:OGI.TODrug Manufacturers - Specialty & Generic
Healthcare
$0.96 -1.43%
-$0.02 today
- Market cap
- $135.37M
- Beta
- 1.84
- P/E (TTM)
- -7.2
- EPS (TTM)
- -$0.19
52W Low $1.37High $3.09
Volume 0.54M
Average 0.19M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$7.59M
FY 2025 · Annual
Investing Cash Flow
-$82.67M
FY 2025 · Annual
Financing Cash Flow
$39.33M
FY 2025 · Annual
-63.5% YoYCash Flow Statement
CAD
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | (130.7M) | (14.28M) | (229.48M) | (45.44M) | (24.76M) |
| Depreciation & Amortization | 31.03M | 24.91M | 24.17M | 12.08M | 17.98M |
| Deferred Income Tax | 42.21M | (88K) | (3.62M) | 0 | (13.77M) |
| Stock-Based Compensation | 3.9M | 5.13M | 5.29M | 7.18M | 4.22M |
| Change in Working Capital | 24.2M | (22.88M) | 12.51M | 14.96M | (2.12M) |
| Accounts Receivables | (6.01M) | (24.02M) | 12.51M | (12.06M) | (15.29M) |
| Inventory | 28.68M | (12.22M) | 0 | 0 | 0 |
| Accounts Payables | 2.06M | 12.15M | 0 | 0 | 0 |
| Other Working Capital | (542K) | 1.21M | (5.52M) | 27.02M | 13.16M |
| Other Non-Cash Items | 776K | (29M) | 155.33M | 15.09M | 12.47M |
| Operating Cash Flow | (28.59M) | (36.21M) | (35.8M) | 3.87M | (7.59M) |
| Capital Expenditures | (12.33M) | (48.78M) | (26.9M) | (5.34M) | (17.05M) |
| Acquisitions (Net) | (2.54M) | (11.06M) | 1.03M | 257K | (65.62M) |
| Purchases of Investments | (120.02M) | (15M) | (10M) | (29.24M) | (1.01M) |
| Sales of Investments | 50.85M | 114.59M | 49.4M | 3.52M | 2.5M |
| Other Investing Activities | (31.08M) | 4.29M | (8.65M) | (7.97M) | (1.52M) |
| Investing Cash Flow | (115.11M) | 44.03M | 1.36M | (38.77M) | (82.67M) |
| Debt Repayment | (116.4M) | (1.01M) | (87K) | (786K) | (60K) |
| Common Stock Issued | 284.88M | 6.34M | 20K | 108.56M | 41.18M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.99M | 6.34M | (750K) | 6K | (1.79M) |
| Financing Cash Flow | 174.46M | 5.33M | (817K) | 107.78M | 39.33M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 313K |
| Net Change in Cash | 30.77M | 13.15M | (34.65M) | 72.88M | (49.01M) |
| Free Cash Flow | (40.92M) | (84.99M) | (62.7M) | (1.47M) | (24.64M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$24.8M
+ D&A$18.0M
+ Stock-Based Comp$4.2M
- Deferred Tax-$13.8M
- Working Capital-$2.1M
+ Other Non-Cash$12.5M
= Operating Cash Flow-$7.6M
- Capex-$17.0M
= Free Cash Flow-$24.6M
Analysis
FY2025 free cash flow is -$24.6M. FCF conversion is 99.5% of net income. Operating cash flow was -$7.6M, with capex of -$17.0M. The largest bridge item is D&A at $18.0M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
No filings found.
Does OGI.TO generate free cash flow?
OrganiGram Holdings Inc. (OGI.TO) generated -$24.64M of free cash flow in fiscal 2025.
How much operating cash flow does OGI.TO produce?
Operating cash flow was -$7.59M, before capital expenditures of $17.05M.
Continue the stock analysis
Jump to another research area for this company.